Table 3.
Hematologic Parameters for SCA Patients with and without Detectable BOLD Activation in Visual Cortex during Visual Stimulation
| SCD cohort [N=23] |
With Activation |
Without Activation |
p value |
|---|---|---|---|
| Hb (g/dl) | 10 (7.4, 11.6) [n=17] |
7.6 (6.2, 10.3) [n=6] |
p = 0.01 |
| HbF (%) | 20.7 (5.8, 32.6) [n=17] |
3.9 (2.1, 21.3) [n=5] |
p = 0.03 |
| ABS Retic. (×106/µL) |
0.14 (0.06, 0.28) [n=17] |
0.21 (0.17, 0.42) [n=5] |
p = 0.01 |
Note: Median values are listed with minimum and maximum in parentheses. N is the total number of SCA patients and n indicates the number of subjects with available data in each subgroup. The Wilcoxon-Mann-Whitney test was used for group difference, and Holm.s procedure was used to adjust p-values for multiple comparisons. Other clinical parameters with no significant difference between the groups of SCA patients are not shown.